Enhanced treatment of cerebral ischemia–Reperfusion injury by intelligent nanocarriers through the regulation of neurovascular units. (15th July 2022)

• Record Type: Journal Article
• Authors: Lu, Hongdan; Li, Shengnan; Dai, Dongwei; Zhang, Qi; Min, Zhiyi; Yang, Chuanzhou; Sun, Shanbo; Ye, Lu; Teng, Chuanhui; Cao, Xiang; Yin, Haoyuan; Lv, Lingyan; Lv, Wei; Xin, Hongliang
• Is Part Of: Acta biomaterialia. Volume 147(2022)
• Page Start: 314
• Page End: 326
• Publication Date: 2022-07-15
• Subjects: Brain targeted drug delivery system -- Nanomedicine -- Cerebral ischemia–reperfusion -- Liposome -- Neurovascular unit; NVU neurovascular unit -- RNS reactive nitrogen species -- OGD/R oxygen and glucose deprivation/reoxygenation -- tMCAO transient middle cerebral artery occlusion/reperfusion -- NF-κB nuclear factor κB -- MMP-9 matrix metalloproteinase-9 -- BBB blood–brain barrier -- NMDAR N-methyl-D-aspartate receptor -- NO nitric oxide -- iNOS inducible nitric oxide synthase -- FPA paraformaldehyde -- ALT alanine transaminase -- AST aspartate transaminase -- CREA creatinine -- BUN blood urea nitrogen -- TEM transmission electron microscopy -- DLS dynamic light scattering; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2022.05.021
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: Reperfusion injury is one of the major causes of disability and death caused by ischemic stroke, and drug development focuses mainly on single neuron protection. However, different kinds of cells in the neurovascular units (NVUs), including neurons, microglia and vascular endothelial cells, are pathologically changed after cerebral ischemia–reperfusion injury, resulting in an urgent need to develop a drug delivery system to comprehensively protect the kinds of cells involved in the NVU. Herein, we have constructed a c(RGDyK) peptide modified, NF-κB inhibitor caffeic acid phenethyl ester (CAPE)-loaded and reactive nitrogen species (RNS) stimuli-responsive liposomal nanocarrier (R-Lipo-CAPE) to target ischemic lesions and then remodel the NVU to reduce the progression of cerebral ischemia–reperfusion injury. The R-Lipo-CAPE liposomes were approximately 170 nm with a zeta potential of -30.8 ± 0.2 mV. The in vitro CAPE release behavior from R-Lipo-CAPE showed an RNS-dependent pattern. For in vivo studies, transient middle cerebral artery occlusion/reperfusion (MCAO) model mice treated with R-Lipo-CAPE had the least neurological impairment and decreased brain tissue damage, with an infarct area of 13%, compared with those treated with saline of 53% or free CAPE of 38%. Furthermore, microglia in the ischemic brain were polarized to the tissue-repairing M2 phenotype after R-Lipo-CAPE treatment. In addition, R-Lipo-CAPE-treated mice displayed a prominent down-regulated expression of MMP-9 and restored expression of the tight junction protein claudin-5. This proof-of-concept indicates that R-Lipo-CAPE is a promising nanomedicine for the treatment of cerebral ischemia–reperfusion injury through the regulation of neurovascular units. Statement of significance: Based on the complex mechanism and difficulty in treatment of cerebral ischemia-reperfusion injury, the overall regulation of neurovascular unit has become an extremely important target. However, little nanomedicine has been directed to remodel the neurovascular units in targeted cerebral ischemia-reperfusion injury therapy. Here, c(RGDyK) peptide modified reactive nitrogen species (RNS) stimuli-responsive liposomal nanocarrier loaded with a NF-κB inhibitor (CAPE), was designed to simultaneously regulate various cells in the microenvironment of cerebral ischemia-reperfusion injury to remodel the neurovascular units. Our in vitro and in vivo data showed that the intelligent nanocarrier exerted the ability of pathological signal stimuli-responsive drug release, cerebral ischemia-reperfusion injury site targeting and neurovascular units remodeling through reducing neuron apoptosis, regulating microglia polarization and repairing vascular endothelial cell. Overall, the intelligent liposomal drug delivery system was a promising and safe nanomedicine in the perspective of cerebral ischemia-reperfusion injury treatment. Graphical abstract: Image, graphical abstract